DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20203289

Covid 19, the Kerala experience: an observational, single centre retrospective study of outcome in covid positive pregnancies

Sabnam S. Nambiar, Ajith S., Reshmi V. P.

Abstract


Background: Covid 19 has spread across the world at an alarming rate. Approximately 4.05 million people have got infected worldwide resulting in around 279,000 deaths. Over 1 million people have recovered worldwide. Aim of this study was to determine whether course and severity of covid 19 is altered in pregnant women and whether covid 19 seemed to worsen the prognosis in pregnant women.

Methods: Around 50 covid positive patients were admitted to this study hospital, a tertiary care referral hospital and medical college, between march and May 2020, 11 were pregnant. Authors collected their data retrospectively to understand the course of their disease till the period of recovery.

Results: There were 6 patients above 31 weeks of whom one had elective repeat caesarean section, one had full term vaginal delivery, one is under follow up. Three patients had foetal distress necessitating emergency caesarean section. Of the remaining 5 patients with periods of gestation between 9-13 weeks, 1 of 24 weeks, 6 patients above 31 weeks, one had a miscarriage. Rest pregnancies are continuing and under follow up. 6 women had been symptomatic at admission, with mild symptoms of low-grade fever, sore throat and rhinitis. All were treated with hydroxychloroquine (HCQs). Those with respiratory symptoms like cough were also treated with oseltamivir. In view of high prevalence of H1N1 in the region. None of the women developed severe disease. The disease did not appear to worsen prognosis in pregnant women. The rate of recovery in pregnant women was similar to that seen in non-pregnant women and also men under the age of 40 years admitted in this study hospital.

Conclusions: Covid 19 did not seem to worsen the prognosis in pregnant individuals when compared to rest of the population. The foetal outcomes also seemed favorable. However larger studies are required before concrete guidelines could be formulated for management of the disease in pregnancy.


Keywords


Caesarean section, Covid 19, Pregnancy, Hydroxychloroquine, Miscarriages, Reverse transcription polymerase chain reaction

Full Text:

PDF

References


Census of India: provisional population totals India: paper 1: census 2011, census India. 2011. Available at: https://censusindia.gov.in/2011-prov-results/prov_results_paper1_india.html. Accessed on 16 April 2020.

Corona virus disease 2019 (covid 19) - symptoms and causes. Mayo Clinic. Available at: https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963. Accessed on 14 April 2020.

Hui DS, Azhar E, Madani TA, Ntoumi, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan China. Int J Infect Dis. 2020;91:264-6.

WHO Director general’s opening remarks at the media briefing on covid 19. World health organization press release. Accessed 12 March 2020.

Symptoms of corona virus. U S Centre for disease control and prevention (CDC). Available at: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Accessed on 14 April 2020.

Q and A on corona virus (covid 19). World health organization archived from the original. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed on 11 March 2020.

Hopkins, Claire. Loss of sense of smell as marker of covid 19 infection. Ear, nose and throat. Surgery body of unitedkingdom. Available at: https://www.entuk.org/sites/default/files/files/Loss%20of%20sense%20of%20smell%20as%20marker%20of%20COVID.pdf. Accessed on 16 April 2020.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. HLH Across Speciality Collaboration. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England). 2020;395(10229):1033.

Q and A on coronaviruses. World health organization (who) archived from the original on 20 Jan 2020. Available at: https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19. Accessed 16 April 2020.

Velavan TP, Meyer CG. The COVID‐19 epidemic. Trop Med Inter Health. 2020;25(3):278.

Q and A on CORONA VIRUS(COVID-19).World Health Organization. Accessed 14 May 2020.

Centers for Disease Control and Prevention (CDC). 2 April 2020. How COVID-19 Spreads. Available at: https://www.researchgate.net/publication/342898659_COVID-19_and_Its_Effect_on_Education_System. Accessed on 16 April 2020.

European Centre for Disease Prevention and Control. Q and A on COVID-19. Available at: https://www.who.int/reproductivehealth/publications/emergencies/COVID-19-SRH/en/. Accessed on 30 April 2020.

Centers for Disease Control and Prevention (CDC). 11 February 2020. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19). Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/lab-biosafety-guidelines.html. Accessed on 26 March 2020.

Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. Am J Roentgenol. 2020:1-7.

American College of Radiology. ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection. ACR website. Advocacy-and Economics/ACR-Position-Statements/Recommenda tions-for-Chest-Radiography-and-CTfor-Suspected-COVID19-Infection. Updated March. 2020 Mar 11;22.

Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020.

Public Health England. Guidance on social distancing for everyone in the UK. Available at: https://www.unity-health.co.uk/covid-19-information-for-patients/government-guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults-2/. Accessed on 26 March 2020.

Centers for disease control and prevention (5 April 2020)-What to Do if You Are Sick. Archived from the original on 14 February 2020. Retrieved 24 April 2020.

World Health Organization (WHO)- When and how to use masks. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks. Accessed on 24 April 2020.

Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature Microbiol. 2020;5(4):562-9.

Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586-90.

Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Inter J Oral Sci. 2020;12(1):8.

Verdecchia P, Cavallini C, Angeli F. The pivotal link between ACE2 deficiency and SARS-COV2 infection. Eur J Intern Med. 2020.

Irani R, Xia Y. Renin angiotensin signalling in normal pregnancy and preeclampsia. Semin Nephrol. 2011;31(1):47-58.

Qiao J. What are the risks of COVID-19 infection in pregnant women?. The Lancet. 2020;395(10226):760-2.

Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 368:m1086.

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemos. 2020;18(5):1094-9.

Murthy S, Gomersall CD, Fowler RA. Care for critically Ill patients with COVID-19. JAMA. 2020;323(15):1499.

World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. In Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: Interim guidance; 2020:21-21.

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infect Dis. 2020;20(5):533-4.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71.

Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020;55(3):105923.

Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14(1):69-71.

Zhou N, Pan T, Zhang J, Li Q, Zhang X, Bai C. Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, middle east respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV). J Biol Chem. 2016;291:9218e32.

Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020:105932.

Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Frontiers Public Health. 2020;8:152.